Facial Injectable Market To Clock 12.0% Cagr During 2016 - 2024, Minimally Invasive Surgeries
For Facial Skin Rejuvenation Gather Steam
The North America facial injectables market is expected to gather momentum from the growing
adoption of facial injectables in skin rejuvenation treatments in the regional population. The
marked affordability of a range of such treatments is a key factor propelling growth in the
regional market. Advances in cosmetology have improved the prospects of minimally invasive
surgeries for facial skin rejuvenation. Expanding array of long-lasting facial fillers has helped key
players in the North America facial injectables market reap large revenue gains over the past
several years. Strides in the overall medical aesthetic market are proportionately advancing
progress in the North America facial injectables market
The North America facial injectables market was estimated at US$2.1 billion in 2015 and is
expected to climb to a valuation of US$5.8 billion by the end of 2024. The regional market is
projected to clock a promising CAGR of 12.0% during 2016 - 2024. Changing concepts of the
role of skin rejuvenation in beauty and aesthetics among worldwide populations are keeping
the regional market increasingly lucrative.
To Get Detailed Overview about the global market report (COVID-19 Impact Analysis):
Some of the top players in the North America facial injectables are Ipsen Group, Galderma S.A.,
Prollenium Medical Technologies Inc., and Merz Pharma & Co. KGaA.
Among the various countries, a leading chunk of the regional revenues come from the U.S. The
status quo is likely to not change in coming years. The vast uptake botulinum toxins and dermal
fillers in the U.S. population is a key factor behind the dominance of this country market.
Expanding Array of Dermal Filler Formulations Expand Potential in Cosmetology
Growing demand for facial fillers to reverse aging among the worldw